Relevance of the OCT1 transporter to the antineoplastic effect of biguanides

Biochemical and Biophysical Research Communications

Volumn 414, Issue 4, 2011, Pages 694-699

  Segal, Eric D ^a,b   Yasmeen, Amber ^a,b   Beauchamp, Marie Claude ^a,b   Rosenblatt, Joshua ^a,b   Pollak, Michael ^b,c   Gotlieb, Walter H ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Biguanides; Cancer; Metformin; Organic cation transporter 1; Phenformin

Indexed keywords

ADENYLATE KINASE; BIGUANIDE DERIVATIVE; METFORMIN; ORGANIC CATION TRANSPORTER 1; PHENFORMIN; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG UPTAKE; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADENYLATE KINASE; ANTINEOPLASTIC AGENTS; BIGUANIDES; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; METFORMIN; ORGANIC CATION TRANSPORTER 1; OVARIAN NEOPLASMS; PHENFORMIN; RNA, SMALL INTERFERING;

EID: 80555149233     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.134     Document Type: Article

References (28)

1. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008, 8:915-928.
2. Wang L.W., Li Z.S., Zou D.W., Jin Z.D., Gao J., Xu G.M. Metformin induces apoptosis of pancreatic cancer cells. World J Gastroenterol 2008, 14:7192-7198.
3. Zakikhani M., Dowling R.J., Sonenberg N., Pollak M.N. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prev Res (Phila) 2008, 1:369-375.
4. Beauchamp M.C., Renier G. Homocysteine induces protein kinase C activation and stimulates c-Fos and lipoprotein lipase expression in macrophages. Diabetes 2002, 51:1180-1187.
5. Gotlieb W.H., Saumet J., Beauchamp M.C., Gu J., Lau S., Pollak M.N., Bruchim I. In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol 2008, 110:246-250.
6. Rattan R., Graham R.P., Maguire J.L., Giri S., Shridhar V. Metformin suppresses ovarian cancer growth and metastasis with enhancement of Cisplatin cytotoxicity in vivo. Neoplasia 2011, 13:483-491.
7. A. Yasmeen, M.C. Beauchamp, E. Piura, E. Segal, M. Pollak, W.H. Gotlieb, Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins. Gynecol Oncol.
8. Dowling R.J., Pollak M., Sonenberg N. Current status and challenges associated with targeting mTOR for cancer therapy. BioDrugs 2009, 23:77-91.
9. Dowling R.J., Zakikhani M., Fantus I.G., Pollak M., Sonenberg N. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 2007, 67:10804-10812.
10. Sakamoto K., Goransson O., Hardie D.G., Alessi D.R. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, Phenformin, and AICAR. Am J Physiol Endocrinol Metab 2004, 287:E310-E317.
11. Kwong S.C., Brubacher J. Phenformin and lactic acidosis: a case report and review. J Emerg Med 1998, 16:881-886.
12. Dilman V.M., Berstein L.M., Zabezhinski M.A., Alexandrov V.A., Bobrov J.F., Pliss G.B. Inhibition of DMBA-induced carcinogenesis by phenformin in the mammary gland of rats. Arch Geschwulstforsch 1978, 48:1-8.
13. Dilman V.M., Anisimov V.N. Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice. Gerontology 1980, 26:241-246.
14. Shikhman A.R., Lebedev K.A., Dil'man V.M. Inhibiting effect of phenformin (phenethyl biguanide) on the growth of Ehrlich carcinoma. Vopr Onkol 1981, 27:67-69.
15. Caraci F., Chisari M., Frasca G., Chiechio S., Salomone S., Pinto A., Sortino M.A., Bianchi A. Effects of phenformin on the proliferation of human tumor cell lines. Life Sci 2003, 74:643-650.
16. Huang X., Wullschleger S., Shpiro N., McGuire V.A., Sakamoto K., Woods Y.L., McBurnie W., Fleming S., Alessi D.R. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. Biochem J 2008, 412:211-221.
17. Nies A.T., Koepsell H., Damme K., Schwab M. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol 2011, 105-167.
18. Sogame Y., Kitamura A., Yabuki M., Komuro S. A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes. Biopharm Drug Dispos 2009, 30:476-484.
19. Shu Y., Sheardown S.A., Brown C., Owen R.P., Zhang S., Castro R.A., Ianculescu A.G., Yue L., Lo J.C., Burchard E.G., Brett C.M., Giacomini K.M. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 2007, 117:1422-1431.
20. Kerb R., Brinkmann U., Chatskaia N., Gorbunov D., Gorboulev V., Mornhinweg E., Keil A., Eichelbaum M., Koepsell H. Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. Pharmacogenetics 2002, 12:591-595.
21. Beauchamp M.C., Knafo A., Yasmeen A., Carboni J.M., Gottardis M.M., Pollak M.N., Gotlieb W.H. BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide. Gynecol Oncol 2009, 115:193-198.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
23. Tzvetkov M.V., Vormfelde S.V., Balen D., Meineke I., Schmidt T., Sehrt D., Sabolic I., Koepsell H., Brockmoller J. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Clin Pharmacol Ther 2009, 86:299-306.
24. Koepsell H., Lips K., Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007, 24:1227-1251.
25. El-Mir M.Y., Nogueira V., Fontaine E., Averet N., Rigoulet M., Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000, 275:223-228.
26. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., Montminy M., Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310:1642-1646.
27. Algire C., Amrein L., Bazile M., David S., Zakikhani M., Pollak M. Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo. Oncogene 2011, 30:1174-1182.
28. Pollak M. Metformin other biguanides in oncology: advancing the research agenda. Cancer Prev Res (Phila) 2010, 3:1060-1065.